BioSensics
Global leader in developing wearable sensors and digital biomarker technologies for clinical trials and research.
Global leader in developing wearable sensors and digital biomarker technologies for clinical trials and research.
BioSensics was founded in 2007 by three scientists from Harvard University with a vision of transforming the healthcare industry through innovative technologies. Since its establishment, BioSensics has created new paradigms in using wearable sensors in healthcare and revolutionized the medical alert industry by creating technologies that are now being used by thousands of older adults. BioSensics solutions encompass comprehensive and validated technologies for collection of digital biomarkers and outcome assessment in healthcare. Our solutions are now empowering novel healthcare initiatives and important clinical trials in a variety of therapeutic areas.
There is no investment information
No recent news or press coverage available for BioSensics.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.